相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Preexisting Adenovirus Seropositivity Is Not Associated With Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials
Kathryn E. Stephenson et al.
JOURNAL OF INFECTIOUS DISEASES (2012)
A Pan-H1 Anti-Hemagglutinin Monoclonal Antibody with Potent Broad-Spectrum Efficacy In Vivo
Gene S. Tan et al.
JOURNAL OF VIROLOGY (2012)
Impact of Preexisting Adenovirus Vector Immunity on Immunogenicity and Protection Conferred with an Adenovirus-Based H5N1 Influenza Vaccine
Aseem Pandey et al.
PLOS ONE (2012)
Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses
Natalie Pica et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Airborne Transmission of Influenza A/H5N1 Virus Between Ferrets
Sander Herfst et al.
SCIENCE (2012)
A recombinant adenovirus expressing immunodominant TB antigens can significantly enhance BCG-induced human immunity
Daniel F. Hoft et al.
VACCINE (2012)
Broadly neutralizing antibodies against influenza virus and prospects for universal therapies
Damian C. Ekiert et al.
CURRENT OPINION IN VIROLOGY (2012)
Serological immunity to adenovirus serotype 5 is not associated with risk of HIV infection: a case-control study
Marcel E. Curlin et al.
AIDS (2011)
Adenoviral Vector Immunity: Its Implications and Circumvention Strategies
Yadvinder S. Ahi et al.
CURRENT GENE THERAPY (2011)
Contributions of Antinucleoprotein IgG to Heterosubtypic Immunity against Influenza Virus
Mark W. LaMere et al.
JOURNAL OF IMMUNOLOGY (2011)
A Highly Conserved Neutralizing Epitope on Group 2 Influenza A Viruses
Damian C. Ekiert et al.
SCIENCE (2011)
Evaluation of age-related differences in the immunogenicity of a G9 H9N2 influenza vaccine
Robert L. Atmar et al.
VACCINE (2011)
Production of adenovirus vectors and their use as a delivery system for influenza vaccines
Sai V. Vemula et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2010)
Avian influenza pandemic preparedness: developing prepandemic and pandemic vaccines against a moving target
Neetu Singh et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2010)
Induction of unnatural immunity: prospects for a broadly protective universal influenza vaccine
Gary J. Nabel et al.
NATURE MEDICINE (2010)
Comparative Efficacy of Hemagglutinin, Nucleoprotein, and Matrix 2 Protein Gene-Based Vaccination against H5N1 Influenza in Mouse and Ferret
Srinivas S. Rao et al.
PLOS ONE (2010)
Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes
Taia T. Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Induction of Broadly Neutralizing H1N1 Influenza Antibodies by Vaccination
Chih-Jen Wei et al.
SCIENCE (2010)
Origins and evolutionary genomics of the 2009 swine-origin H1N1 influenza A epidemic
Gavin J. D. Smith et al.
NATURE (2009)
Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses
Jianhua Sui et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2009)
Cross-Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus.
Kathy Hancock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The public health impact of avian influenza viruses
J. M. Katz et al.
POULTRY SCIENCE (2009)
Antibody Recognition of a Highly Conserved Influenza Virus Epitope
Damian C. Ekiert et al.
SCIENCE (2009)
A phase I clinical trial of a PER.C6® cell grown influenza H7 virus vaccine
Rebecca J. Cox et al.
VACCINE (2009)
Comparative analysis of vector biodistribution, persistence and gene expression following intravenous delivery of bovine, porcine and human adenoviral vectors in a mouse model
Anurag Sharma et al.
VIROLOGY (2009)
Past, Present, and Possible Future Human Infection with Influenza Virus A Subtype H7
Jessica A. Belser et al.
EMERGING INFECTIOUS DISEASES (2009)
A novel role for non-neutralizing antibodies against nucleoprotein in facilitating resistance to influenza virus
Damian M. Carragher et al.
JOURNAL OF IMMUNOLOGY (2008)
Immune responses of healthy subjects to a single dose of intramuscular inactivated influenza A/Vietnam/1203/2004 (H5N1) vaccine after priming with an antigenic variant
Nega Ali Goji et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
A broadly protective vaccine against globally dispersed clade 1 and clade 2 H5N1 influenza viruses
Mary A. Hoelscher et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case-cohort analysis
M. Juliana McElrath et al.
LANCET (2008)
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial
Susan P. Buchbinder et al.
LANCET (2008)
Bovine adenoviral vector-based H5N1 influenza vaccine overcomes exceptionally high levels of pre-existing immunity against human adenovirus
Neetu Singh et al.
MOLECULAR THERAPY (2008)
Antigenically distinct MF59-adjuvanted vaccine to boost immunity to H5N1
Iain Stephenson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
New pre-pandemic influenza vaccines: An egg- and adjuvant-independent human adenoviral vector strategy induces long-lasting protective immune responses in mice
M. A. Hoelscher et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Development and evaluation of an influenza virus subtype H7N2 vaccine candidate for pandemic preparedness
Claudia Pappas et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Partial protection against H5N1 influenza in mice with a single dose of a chimpanzee adenovirus vector expressing nucleoprotein
Soumitra Roy et al.
VACCINE (2007)
Scientific barriers to developing vaccines against avian influenza viruses
Kanta Subbarao et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice
MA Hoelscher et al.
LANCET (2006)
Cell-mediated protection in influenza infection
PG Thomas et al.
EMERGING INFECTIOUS DISEASES (2006)
Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein
SL Epstein et al.
VACCINE (2005)
Identification of a linear peptide recognized by monoclonal antibody 2D7 capable of generating CCR5-Specific antibodies with human immunodeficiency virus-neutralizing activity
S Khurana et al.
JOURNAL OF VIROLOGY (2005)
Safety and immunogenicity of adenovirus-vectored nasal and epicutaneous influenza vaccines in humans
KR Van Kampen et al.
VACCINE (2005)
Public health risk from avian influenza viruses
ML Perdue et al.
AVIAN DISEASES (2005)
Porcine adenoviral vectors evade preexisting humoral immunity to adenoviruses and efficiently infect both human and murine cells in culture
DS Bangari et al.
VIRUS RESEARCH (2004)
Development and characterization of bovine x human hybrid cell lines that efficiently support the replication of both wild-type bovine and human adenoviruses and those with E1 deleted
AL van Olphen et al.
JOURNAL OF VIROLOGY (2002)
The influenza virus nucleoprotein: a multifunctional RNA-binding protein pivotal to virus replication
A Portela et al.
JOURNAL OF GENERAL VIROLOGY (2002)
Characterization of a human H9N2 influenza virus isolated in Hong Kong
T Saito et al.
VACCINE (2001)
分享论文
